Bionano Genomics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $40.0M | $377.1M | $24.6M |
| FY2022 | $58.1M | $307.5M | $5.1M |
| FY2023 | $118.2M | $214.4M | $17.9M |
| FY2024 | $41.3M | $76.7M | $9.2M |
| FY2025 | $29.2M | $73.6M | $3.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $40.0M | $377.1M | $24.6M |
| FY2022 | $58.1M | $307.5M | $5.1M |
| FY2023 | $118.2M | $214.4M | $17.9M |
| FY2024 | $41.3M | $76.7M | $9.2M |
| FY2025 | $29.2M | $73.6M | $3.0M |